bool(true)
object(WP_Post)#3040 (24) {
  ["ID"]=>
  int(19536)
  ["post_author"]=>
  string(1) "1"
  ["post_date"]=>
  string(19) "2024-03-05 16:11:44"
  ["post_date_gmt"]=>
  string(19) "2024-03-05 23:11:44"
  ["post_content"]=>
  string(2878) "

Cascadia Capital, an investment bank serving middle market clients globally, is pleased to announce it acted as the exclusive financial advisor to Fertility Specialists of Texas ("FST"), as it joins First Fertility’s network of high-performing family building centers. This transaction is Cascadia's eighth successful engagement in advising clients within the reproductive health sector.

“We are delighted with the culmination of this transaction, uniting a well-regarded regional leader in reproductive health with the esteemed First Fertility network. This strategic addition marks a significant expansion into the Texas market, aligning seamlessly with the company's overarching vision to surpass conventional standards in fertility care through the delivery of unparalleled services. Our involvement in facilitating this prosperous partnership underscores Cascadia's expertise and commitment to the fertility sector, with this transaction representing the eighth successful partnership we have advised on," remarked Vitaliy Marchenko, Director at Cascadia.

With a flagship office and IVF lab located in Plano, Texas, FST is a renowned fertility center that has consistently showcased its commitment to compassionate and cutting-edge fertility treatments since its inception in 2005. By delivering top-notch patient service and exceptional pregnancy success rates, FST has grown tremendously with a team of six world-renowned, board-certified physicians and six practice locations throughout the Dallas-Fort Worth Metroplex.

First Fertility continues to solidify its position as one of the most rapidly expanding physician-centered fertility care networks in the nation. Backed by Sverica Capital, First Fertility fosters collaboration among physicians and medical leaders, providing fertility-focused practices with a strong foundation for innovation and growth.

“As the founder and medical director of Fertility Specialists of Texas, I am immensely excited to embark on this incredible journey alongside First Fertility,” adds Jerald Goldstein, MD. “This partnership represents a remarkable opportunity to unite our expertise and passion for reproductive medicine, driving us to reach new heights in assisting individuals and couples on their path to parenthood. Together, we will shape the future of fertility with compassion and unparalleled personalized care, as we continue to help patients from Texas, throughout the country, and around the world, to fulfill their family-building dreams."


" ["post_title"]=> string(125) "Cascadia Advises Fertility Specialists of Texas in its Acquisition by First Fertility, a portfolio company of Sverica Capital" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(6) "closed" ["post_password"]=> string(0) "" ["post_name"]=> string(124) "cascadia-advises-fertility-specialists-of-texas-in-its-acquisition-by-first-fertility-a-portfolio-company-of-sverica-capital" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2024-03-06 13:54:59" ["post_modified_gmt"]=> string(19) "2024-03-06 20:54:59" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(60) "https://www.cascadiacapital.com/?post_type=news&p=19536" ["menu_order"]=> int(0) ["post_type"]=> string(4) "news" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" }
object(WP_Query)#1653 (55) {
  ["query"]=>
  array(1) {
    ["industry-categories"]=>
    string(10) "healthcare"
  }
  ["query_vars"]=>
  array(68) {
    ["industry-categories"]=>
    string(10) "healthcare"
    ["error"]=>
    string(0) ""
    ["m"]=>
    string(0) ""
    ["p"]=>
    int(0)
    ["post_parent"]=>
    string(0) ""
    ["subpost"]=>
    string(0) ""
    ["subpost_id"]=>
    string(0) ""
    ["attachment"]=>
    string(0) ""
    ["attachment_id"]=>
    int(0)
    ["name"]=>
    string(0) ""
    ["pagename"]=>
    string(0) ""
    ["page_id"]=>
    int(0)
    ["second"]=>
    string(0) ""
    ["minute"]=>
    string(0) ""
    ["hour"]=>
    string(0) ""
    ["day"]=>
    int(0)
    ["monthnum"]=>
    int(0)
    ["year"]=>
    int(0)
    ["w"]=>
    int(0)
    ["category_name"]=>
    string(0) ""
    ["tag"]=>
    string(0) ""
    ["cat"]=>
    string(0) ""
    ["tag_id"]=>
    string(0) ""
    ["author"]=>
    string(0) ""
    ["author_name"]=>
    string(0) ""
    ["feed"]=>
    string(0) ""
    ["tb"]=>
    string(0) ""
    ["paged"]=>
    int(0)
    ["meta_key"]=>
    string(0) ""
    ["meta_value"]=>
    string(0) ""
    ["preview"]=>
    string(0) ""
    ["s"]=>
    string(0) ""
    ["sentence"]=>
    string(0) ""
    ["title"]=>
    string(0) ""
    ["fields"]=>
    string(0) ""
    ["menu_order"]=>
    string(0) ""
    ["embed"]=>
    string(0) ""
    ["category__in"]=>
    array(0) {
    }
    ["category__not_in"]=>
    array(0) {
    }
    ["category__and"]=>
    array(0) {
    }
    ["post__in"]=>
    array(0) {
    }
    ["post__not_in"]=>
    array(0) {
    }
    ["post_name__in"]=>
    array(0) {
    }
    ["tag__in"]=>
    array(0) {
    }
    ["tag__not_in"]=>
    array(0) {
    }
    ["tag__and"]=>
    array(0) {
    }
    ["tag_slug__in"]=>
    array(0) {
    }
    ["tag_slug__and"]=>
    array(0) {
    }
    ["post_parent__in"]=>
    array(0) {
    }
    ["post_parent__not_in"]=>
    array(0) {
    }
    ["author__in"]=>
    array(0) {
    }
    ["author__not_in"]=>
    array(0) {
    }
    ["search_columns"]=>
    array(0) {
    }
    ["ignore_sticky_posts"]=>
    bool(false)
    ["suppress_filters"]=>
    bool(false)
    ["cache_results"]=>
    bool(true)
    ["update_post_term_cache"]=>
    bool(true)
    ["update_menu_item_cache"]=>
    bool(false)
    ["lazy_load_term_meta"]=>
    bool(true)
    ["update_post_meta_cache"]=>
    bool(true)
    ["post_type"]=>
    string(0) ""
    ["posts_per_page"]=>
    int(20)
    ["nopaging"]=>
    bool(false)
    ["comments_per_page"]=>
    string(2) "50"
    ["no_found_rows"]=>
    bool(false)
    ["taxonomy"]=>
    string(19) "industry-categories"
    ["term"]=>
    string(10) "healthcare"
    ["order"]=>
    string(4) "DESC"
  }
  ["tax_query"]=>
  object(WP_Tax_Query)#3037 (6) {
    ["queries"]=>
    array(1) {
      [0]=>
      array(5) {
        ["taxonomy"]=>
        string(19) "industry-categories"
        ["terms"]=>
        array(1) {
          [0]=>
          string(10) "healthcare"
        }
        ["field"]=>
        string(4) "slug"
        ["operator"]=>
        string(2) "IN"
        ["include_children"]=>
        bool(true)
      }
    }
    ["relation"]=>
    string(3) "AND"
    ["table_aliases":protected]=>
    array(1) {
      [0]=>
      string(23) "cscd_term_relationships"
    }
    ["queried_terms"]=>
    array(1) {
      ["industry-categories"]=>
      array(2) {
        ["terms"]=>
        array(1) {
          [0]=>
          string(10) "healthcare"
        }
        ["field"]=>
        string(4) "slug"
      }
    }
    ["primary_table"]=>
    string(10) "cscd_posts"
    ["primary_id_column"]=>
    string(2) "ID"
  }
  ["meta_query"]=>
  object(WP_Meta_Query)#3036 (9) {
    ["queries"]=>
    array(0) {
    }
    ["relation"]=>
    NULL
    ["meta_table"]=>
    NULL
    ["meta_id_column"]=>
    NULL
    ["primary_table"]=>
    NULL
    ["primary_id_column"]=>
    NULL
    ["table_aliases":protected]=>
    array(0) {
    }
    ["clauses":protected]=>
    array(0) {
    }
    ["has_or_relation":protected]=>
    bool(false)
  }
  ["date_query"]=>
  bool(false)
  ["queried_object"]=>
  object(WP_Term)#3784 (11) {
    ["term_id"]=>
    int(97)
    ["name"]=>
    string(10) "Healthcare"
    ["slug"]=>
    string(10) "healthcare"
    ["term_group"]=>
    int(0)
    ["term_taxonomy_id"]=>
    int(97)
    ["taxonomy"]=>
    string(19) "industry-categories"
    ["description"]=>
    string(0) ""
    ["parent"]=>
    int(0)
    ["count"]=>
    int(183)
    ["filter"]=>
    string(3) "raw"
    ["term_order"]=>
    string(1) "7"
  }
  ["queried_object_id"]=>
  int(97)
  ["request"]=>
  string(1185) "SELECT SQL_CALC_FOUND_ROWS  cscd_posts.ID
					 FROM cscd_posts  LEFT JOIN cscd_term_relationships ON (cscd_posts.ID = cscd_term_relationships.object_id)
					 WHERE 1=1  AND ( 
  cscd_term_relationships.term_taxonomy_id IN (97)
) AND ((cscd_posts.post_type = 'team' AND (cscd_posts.post_status = 'publish' OR cscd_posts.post_status = 'acf-disabled')) OR (cscd_posts.post_type = 'news' AND (cscd_posts.post_status = 'publish' OR cscd_posts.post_status = 'acf-disabled')) OR (cscd_posts.post_type = 'in-the-news' AND (cscd_posts.post_status = 'publish' OR cscd_posts.post_status = 'acf-disabled')) OR (cscd_posts.post_type = 'events' AND (cscd_posts.post_status = 'publish' OR cscd_posts.post_status = 'acf-disabled')) OR (cscd_posts.post_type = 'case-studies' AND (cscd_posts.post_status = 'publish' OR cscd_posts.post_status = 'acf-disabled')) OR (cscd_posts.post_type = 'transactions' AND (cscd_posts.post_status = 'publish' OR cscd_posts.post_status = 'acf-disabled')) OR (cscd_posts.post_type = 'industries' AND (cscd_posts.post_status = 'publish' OR cscd_posts.post_status = 'acf-disabled')))
					 GROUP BY cscd_posts.ID
					 ORDER BY cscd_posts.post_date DESC
					 LIMIT 0, 20"
  ["posts"]=>
  &array(20) {
    [0]=>
    object(WP_Post)#3040 (24) {
      ["ID"]=>
      int(19536)
      ["post_author"]=>
      string(1) "1"
      ["post_date"]=>
      string(19) "2024-03-05 16:11:44"
      ["post_date_gmt"]=>
      string(19) "2024-03-05 23:11:44"
      ["post_content"]=>
      string(2878) "

Cascadia Capital, an investment bank serving middle market clients globally, is pleased to announce it acted as the exclusive financial advisor to Fertility Specialists of Texas ("FST"), as it joins First Fertility’s network of high-performing family building centers. This transaction is Cascadia's eighth successful engagement in advising clients within the reproductive health sector.

“We are delighted with the culmination of this transaction, uniting a well-regarded regional leader in reproductive health with the esteemed First Fertility network. This strategic addition marks a significant expansion into the Texas market, aligning seamlessly with the company's overarching vision to surpass conventional standards in fertility care through the delivery of unparalleled services. Our involvement in facilitating this prosperous partnership underscores Cascadia's expertise and commitment to the fertility sector, with this transaction representing the eighth successful partnership we have advised on," remarked Vitaliy Marchenko, Director at Cascadia.

With a flagship office and IVF lab located in Plano, Texas, FST is a renowned fertility center that has consistently showcased its commitment to compassionate and cutting-edge fertility treatments since its inception in 2005. By delivering top-notch patient service and exceptional pregnancy success rates, FST has grown tremendously with a team of six world-renowned, board-certified physicians and six practice locations throughout the Dallas-Fort Worth Metroplex.

First Fertility continues to solidify its position as one of the most rapidly expanding physician-centered fertility care networks in the nation. Backed by Sverica Capital, First Fertility fosters collaboration among physicians and medical leaders, providing fertility-focused practices with a strong foundation for innovation and growth.

“As the founder and medical director of Fertility Specialists of Texas, I am immensely excited to embark on this incredible journey alongside First Fertility,” adds Jerald Goldstein, MD. “This partnership represents a remarkable opportunity to unite our expertise and passion for reproductive medicine, driving us to reach new heights in assisting individuals and couples on their path to parenthood. Together, we will shape the future of fertility with compassion and unparalleled personalized care, as we continue to help patients from Texas, throughout the country, and around the world, to fulfill their family-building dreams."


" ["post_title"]=> string(125) "Cascadia Advises Fertility Specialists of Texas in its Acquisition by First Fertility, a portfolio company of Sverica Capital" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(6) "closed" ["post_password"]=> string(0) "" ["post_name"]=> string(124) "cascadia-advises-fertility-specialists-of-texas-in-its-acquisition-by-first-fertility-a-portfolio-company-of-sverica-capital" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2024-03-06 13:54:59" ["post_modified_gmt"]=> string(19) "2024-03-06 20:54:59" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(60) "https://www.cascadiacapital.com/?post_type=news&p=19536" ["menu_order"]=> int(0) ["post_type"]=> string(4) "news" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" } [1]=> object(WP_Post)#3044 (24) { ["ID"]=> int(19525) ["post_author"]=> string(1) "1" ["post_date"]=> string(19) "2024-02-29 13:26:00" ["post_date_gmt"]=> string(19) "2024-02-29 20:26:00" ["post_content"]=> string(0) "" ["post_title"]=> string(48) "Fertility Specialists of Texas / First Fertility" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(6) "closed" ["post_password"]=> string(0) "" ["post_name"]=> string(46) "fertility-specialists-of-texas-first-fertility" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2024-03-05 15:49:52" ["post_modified_gmt"]=> string(19) "2024-03-05 22:49:52" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(68) "https://www.cascadiacapital.com/?post_type=transactions&p=19525" ["menu_order"]=> int(0) ["post_type"]=> string(12) "transactions" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" } [2]=> object(WP_Post)#3035 (24) { ["ID"]=> int(19433) ["post_author"]=> string(1) "1" ["post_date"]=> string(19) "2024-02-27 03:03:00" ["post_date_gmt"]=> string(19) "2024-02-27 10:03:00" ["post_content"]=> string(3625) "

Cascadia Capital, an investment bank serving middle market clients globally, today announced it acted as the exclusive financial advisor to Concord Technologies (“Concord”), a leading provider of secure document exchange and workflow automation solutions, in its acquisition of Biscom, Inc. (“Biscom”), a provider of on-premises enterprise fax and secure file transfer solutions. Cascadia previously advised Concord on the sale of a minority interest to Excellere Partners in January 2019.

Concord Technologies is a provider of cloud-based fax, intelligent document automation and workflow solutions to healthcare providers and payers. For more than 20 years, billions of sensitive records containing valuable patient information have been accurately and securely sent and received using Concord’s Cloud Fax suite of solutions. The company is also recognized for its leadership position of creating artificial intelligence technologies and industry-leading applications that help its customers grow and manage their business.

Biscom has been at the forefront of advancing secure data exchanges for mission-critical information for more than three and a half decades. The company prides itself on helping customers architect enterprise communication infrastructures that alleviate real world challenges no matter the organization technology stack or regulation requirements. Cloud-based, on premises, or hybrid, Biscom’s flexible digital fax, secure messaging, and workflow automation solutions work together with existing systems to prevent organizational bottlenecks that impact productivity and profitability.

Together, these organizations serve over 4,500 customers and process over 4 billion pages of protected information every year, creating a new industry powerhouse and the largest provider offering secure document exchange and workflow automation solutions across on-premises, hybrid, and cloud fax architectures, alongside a suite of complementary interoperability, data extraction, and workflow tools.

“Both Concord and Biscom have proven records of innovation, impressive industry reputations and unwavering dedication to customers,” said Chris Moore, Founder and CEO of Concord Technologies. “We are committed to building on this strong foundation to help solve the industry’s most critical challenges in exchanging, accessing, and integrating protected data. Our goal is to give customers added peace of mind that they are working with a partner that can solve their technology challenges now and provide innovative solutions well into the future.”

“The addition of Biscom to the Concord platform further establishes Concord as a leader in healthcare interoperability and automation,” said Kevin Cable, Cascadia Managing Director. “This is an exceptional outcome for a great client, and our firm is proud to have represented Concord through their continued growth.”

“It was great to work with and continue to build a relationship with Kevin Cable and the Cascadia team,” added Moore. “Cascadia played a vital role in helping to lead and negotiate a successful transaction.”
Related Transactions


" ["post_title"]=> string(68) "Cascadia Advises Concord Technologies in Acquisition of Biscom, Inc." ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(6) "closed" ["post_password"]=> string(0) "" ["post_name"]=> string(66) "cascadia-advises-concord-technologies-in-acquisition-of-biscom-inc" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2024-02-26 16:35:35" ["post_modified_gmt"]=> string(19) "2024-02-26 23:35:35" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(60) "https://www.cascadiacapital.com/?post_type=news&p=19433" ["menu_order"]=> int(0) ["post_type"]=> string(4) "news" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" } [3]=> object(WP_Post)#3038 (24) { ["ID"]=> int(19068) ["post_author"]=> string(1) "1" ["post_date"]=> string(19) "2024-02-14 05:00:00" ["post_date_gmt"]=> string(19) "2024-02-14 12:00:00" ["post_content"]=> string(3469) "

Cascadia Capital, one of the nation’s most active independent middle-market investment banks, is pleased to welcome Ben Freking as the newest Director in the firm’s Healthcare group. Ben brings over a decade of experience and a wealth of expertise in providing strategic advice and transaction services to clients with outsourced services business models, including facility and equipment services, professional services, human capital services, and education and training services. At Cascadia, he will be focused on serving clients and financial sponsors investing at the cross section of healthcare and outsourced management services, including medical equipment service, healthcare management services, and other outsourced provider services.

"I am thrilled to join Cascadia Capital and be part of a team that has a robust reputation for delivering extraordinary results in the healthcare sector," said Ben Freking. "I have actively advised clients across the professional and technical services landscape, developing a particular affinity for clients who serve the healthcare end market."

Prior to joining Cascadia, Mr. Freking spent several years at Lazard, primarily advising sponsor-backed companies. During this time, he cultivated a deep understanding of M&A value drivers and differentiators for service-based transactions. His expertise and strategic insights make him a valuable addition to Cascadia’s Healthcare team. Mr. Freking began his career at PricewaterhouseCoopers (PwC), where he honed a highly technical skillset as a CPA.

"We are excited to welcome Ben to the Healthcare team," said Adam Stormoen, Managing Director and Head of the Healthcare group at Cascadia. "His deep domain expertise around prominent areas of focus for our Healthcare team and a proven track record as an exceptional banker will further enhance our capabilities and reinforce our commitment to delivering top-notch service to our clients."

Cascadia Capital is confident that Ben's addition to the team will not only strengthen the firm's position as a trusted advisor but also contribute significantly to the success of its healthcare-focused transactions.

“We are thrilled to have Ben join our esteemed Healthcare practice,” added Cascadia CEO & Chairman Michael Butler. “Adding a banker of Ben’s caliber to our senior leadership team aligns with our mission to assemble a top-tier team of professionals capable of navigating the complexities of the evolving market landscape. With a growing team and a keen eye on market opportunities, Cascadia is better positioned than ever to serve our clients with excellence."

To connect with Mr. Freking, please reach out to bfreking@cascadiacapital.com.

" ["post_title"]=> string(98) "Cascadia Expands Healthcare Investment Banking Expertise with Addition of New Director Ben Freking" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(6) "closed" ["post_password"]=> string(0) "" ["post_name"]=> string(23) "ben-freking-new-diretor" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2024-02-28 09:45:37" ["post_modified_gmt"]=> string(19) "2024-02-28 16:45:37" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(60) "https://www.cascadiacapital.com/?post_type=news&p=19068" ["menu_order"]=> int(0) ["post_type"]=> string(4) "news" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" } [4]=> object(WP_Post)#3042 (24) { ["ID"]=> int(19078) ["post_author"]=> string(1) "1" ["post_date"]=> string(19) "2024-02-13 14:51:32" ["post_date_gmt"]=> string(19) "2024-02-13 21:51:32" ["post_content"]=> string(0) "" ["post_title"]=> string(14) "Summit Imaging" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(6) "closed" ["post_password"]=> string(0) "" ["post_name"]=> string(14) "summit-imaging" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2024-02-13 17:52:33" ["post_modified_gmt"]=> string(19) "2024-02-14 00:52:33" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(68) "https://www.cascadiacapital.com/?post_type=case-studies&p=19078" ["menu_order"]=> int(0) ["post_type"]=> string(12) "case-studies" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" } [5]=> object(WP_Post)#3045 (24) { ["ID"]=> int(19073) ["post_author"]=> string(1) "1" ["post_date"]=> string(19) "2024-02-13 14:45:37" ["post_date_gmt"]=> string(19) "2024-02-13 21:45:37" ["post_content"]=> string(0) "" ["post_title"]=> string(3) "626" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(6) "closed" ["post_password"]=> string(0) "" ["post_name"]=> string(3) "626" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2024-02-13 14:45:41" ["post_modified_gmt"]=> string(19) "2024-02-13 21:45:41" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(68) "https://www.cascadiacapital.com/?post_type=case-studies&p=19073" ["menu_order"]=> int(0) ["post_type"]=> string(12) "case-studies" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" } [6]=> object(WP_Post)#3046 (24) { ["ID"]=> int(19053) ["post_author"]=> string(1) "1" ["post_date"]=> string(19) "2024-02-13 10:30:51" ["post_date_gmt"]=> string(19) "2024-02-13 17:30:51" ["post_content"]=> string(622) "

Ben Freking is a Director in Cascadia’s Healthcare group, specializing in providing strategic advice and transaction services to medical equipment service and healthcare facility service providers.

Ben joined Cascadia after nearly seven years at Lazard in the firm’s Business Services practice. Prior to Lazard, Ben spent several years at PricewaterhouseCoopers. He holds a Master in Accountancy from the University of Minnesota and a Bachelor of Science in Business Administration from Colorado State University.

" ["post_title"]=> string(11) "Ben Freking" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(6) "closed" ["post_password"]=> string(0) "" ["post_name"]=> string(11) "ben-freking" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2024-02-13 14:53:10" ["post_modified_gmt"]=> string(19) "2024-02-13 21:53:10" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(60) "https://www.cascadiacapital.com/?post_type=team&p=19053" ["menu_order"]=> int(0) ["post_type"]=> string(4) "team" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" } [7]=> object(WP_Post)#3047 (24) { ["ID"]=> int(19059) ["post_author"]=> string(1) "1" ["post_date"]=> string(19) "2024-02-12 14:25:13" ["post_date_gmt"]=> string(19) "2024-02-12 21:25:13" ["post_content"]=> string(0) "" ["post_title"]=> string(36) "Medical Equipment Newsletter H2-2023" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(6) "closed" ["post_password"]=> string(0) "" ["post_name"]=> string(33) "medical-equipment-newsletter-2h23" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2024-02-12 14:25:16" ["post_modified_gmt"]=> string(19) "2024-02-12 21:25:16" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(60) "https://www.cascadiacapital.com/?post_type=news&p=19059" ["menu_order"]=> int(0) ["post_type"]=> string(4) "news" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" } [8]=> object(WP_Post)#3048 (24) { ["ID"]=> int(19092) ["post_author"]=> string(1) "1" ["post_date"]=> string(19) "2023-12-20 10:01:00" ["post_date_gmt"]=> string(19) "2023-12-20 17:01:00" ["post_content"]=> string(0) "" ["post_title"]=> string(16) "Concord / Biscom" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(6) "closed" ["post_password"]=> string(0) "" ["post_name"]=> string(14) "concord-biscom" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2024-02-14 10:04:03" ["post_modified_gmt"]=> string(19) "2024-02-14 17:04:03" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(68) "https://www.cascadiacapital.com/?post_type=transactions&p=19092" ["menu_order"]=> int(0) ["post_type"]=> string(12) "transactions" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" } [9]=> object(WP_Post)#3049 (24) { ["ID"]=> int(18215) ["post_author"]=> string(1) "1" ["post_date"]=> string(19) "2023-10-18 14:28:21" ["post_date_gmt"]=> string(19) "2023-10-18 21:28:21" ["post_content"]=> string(2239) "

Cascadia Capital, an investment bank serving middle market clients globally, today announced that it acted as the exclusive financial advisor to MedQIA, LLC on its merger with WorldCare Clinical, a portfolio company of DFW Capital, to form Voiant.

Founded in 2007 and headquartered in Los Angeles, MedQIA provides clients with an automated technology platform to manage imaging and sites for their clinical trials, with full operational support services on demand. The company utilizes artificial intelligence to modernize image workflow within clinical trials and image analysis helping clients perform trials with better efficiency, increased quality with a quicker turnaround, accelerating trial timelines to improve drug discovery and bringing state-of-the-art care to patients. 

MedQIA, WorldCare Clinical and DARC are excited to announce their merger and the launch of their newly rebranded organization: Voiant, LLC. The strategic move aims to consolidate an industry-leading AI-based clinical trial imaging platform with unparalleled scientific and clinical domain expertise, providing biopharmaceutical organization with high-speed delivery of quality clinical endpoint data.

“This combination will allow MedQIA to accelerate its growth and increase its market share within the industry,” said Adam Stormoen, Managing Director at Cascadia Capital. “We are pleased to have delivered another successful outcome in the clinical trials sub-vertical and look forward to continuing to support clients in the space.”  

"Cascadia's ability to rapidly understand our business and their experienced and dedicated team were instrumental in helping our team to navigate an extremely complex transaction, which ultimately resulted in a deal closely aligned with MedQIA's growth objectives and expertise in the global clinical trials ecosystem," said Jonathan Goldin, MedQIA Co-Founder. "This deal will facilitate and accelerate our vision to use advanced technology to revolutionize the management of the imaging aspect of drug and device clinical trials."

" ["post_title"]=> string(113) "Cascadia Advises MedQIA on its Merger with WorldCare Clinical, a Portfolio Company of DFW Capital, to form Voiant" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(6) "closed" ["post_password"]=> string(0) "" ["post_name"]=> string(111) "cascadia-advises-medqia-on-its-merger-with-worldcare-clinical-a-portfolio-company-of-dfw-capital-to-form-voiant" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2023-10-19 08:32:54" ["post_modified_gmt"]=> string(19) "2023-10-19 15:32:54" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(60) "https://www.cascadiacapital.com/?post_type=news&p=18215" ["menu_order"]=> int(0) ["post_type"]=> string(4) "news" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" } [10]=> object(WP_Post)#3050 (24) { ["ID"]=> int(17831) ["post_author"]=> string(1) "1" ["post_date"]=> string(19) "2023-09-14 17:09:13" ["post_date_gmt"]=> string(19) "2023-09-15 00:09:13" ["post_content"]=> string(0) "" ["post_title"]=> string(18) "MedQIA / WorldCare" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(6) "closed" ["post_password"]=> string(0) "" ["post_name"]=> string(16) "medqia-worldcare" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2023-09-21 11:30:05" ["post_modified_gmt"]=> string(19) "2023-09-21 18:30:05" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(68) "https://www.cascadiacapital.com/?post_type=transactions&p=17831" ["menu_order"]=> int(0) ["post_type"]=> string(12) "transactions" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" } [11]=> object(WP_Post)#3051 (24) { ["ID"]=> int(18033) ["post_author"]=> string(1) "1" ["post_date"]=> string(19) "2023-08-31 11:20:00" ["post_date_gmt"]=> string(19) "2023-08-31 18:20:00" ["post_content"]=> string(3097) "

Cascadia Capital, an investment bank serving middle market clients globally, today announced it acted as the exclusive financial advisor to Retina Consultants of Southern Colorado (“RCSC”) in its acquisition by Retina Consultants of America (“RCA”), a comprehensive physician management services organization. With six board-certified physicians and three clinic locations, RCSC’s partnership bolsters RCA’s Colorado footprint and furthers its influence in innovative retina research across the U.S. RCA now has a total network of more than 235 physicians across more than 300 locations. 

Established in 1987, RCSC physicians specialize in the treatment of retinal diseases, laser procedures and surgery, using state-of-the-art diagnostic testing equipment, lasers, surgical instruments, research, and studies to further enhance each diagnosis, condition, and treatment. In addition to delivering exceptional patient care, RCSC’s renowned team of physicians are recognized leaders for their publications and participation in retinal research and clinical trials. Together with RCA, the physicians, and dedicated staff of RCSC look forward to continuing their involvement in groundbreaking clinical studies in an effort to ensure patients receive the latest innovative procedures and therapies.  

"Retina Consultants of Southern Colorado is thrilled to partner with RCA to achieve synergy in providing the highest quality and most technologically advanced retina care along with many of the most prestigious, innovative, and forward-thinking practices in the nation,” said Adam Martidis, M.D., Retina Consultants of Southern Colorado.

“Cascadia was pivotal in securing a highly successful outcome in the acquisition of our medical practice,” continued Dr. Martidis. “Their actions and guidance can best be described as smart, strategic, patient, and efficient. There is no way we could have achieved the outstanding result in our deal without their unparalleled professionalism, strict attention to detail, and stellar advocacy.”

“Cascadia is pleased to have played a part in orchestrating a transaction uniting two exceptionally driven parties,” said Vitaliy Marchenko, Cascadia Director. “We are excited to have helped pave the way for this remarkable outcome and an even more promising future partnership.”

Physician partnership and consolidation has become one of the dominant recent trends in the healthcare landscape. Cascadia has been a key advisor to clinics and doctors interested in exploring or taking advantage of this market dynamic. Our team has worked with retina, ophthalmology, gastroenterology, fertility, dermatology, cardio and vascular, and many other physicians interested in exploring strategic opportunities.  

" ["post_title"]=> string(108) "Cascadia Advises Retina Consultants of Southern Colorado in its Acquisition by Retina Consultants of America" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(6) "closed" ["post_password"]=> string(0) "" ["post_name"]=> string(108) "cascadia-advises-retina-consultants-of-southern-colorado-in-its-acquisition-by-retina-consultants-of-america" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2023-10-31 15:10:26" ["post_modified_gmt"]=> string(19) "2023-10-31 22:10:26" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(60) "https://www.cascadiacapital.com/?post_type=news&p=18033" ["menu_order"]=> int(0) ["post_type"]=> string(4) "news" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" } [12]=> object(WP_Post)#3052 (24) { ["ID"]=> int(18034) ["post_author"]=> string(1) "1" ["post_date"]=> string(19) "2023-08-31 09:43:59" ["post_date_gmt"]=> string(19) "2023-08-31 16:43:59" ["post_content"]=> string(0) "" ["post_title"]=> string(39) "Retina Consultants of Southern Colorado" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(6) "closed" ["post_password"]=> string(0) "" ["post_name"]=> string(39) "retina-consultants-of-southern-colorado" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2023-09-21 08:58:02" ["post_modified_gmt"]=> string(19) "2023-09-21 15:58:02" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(68) "https://www.cascadiacapital.com/?post_type=transactions&p=18034" ["menu_order"]=> int(0) ["post_type"]=> string(12) "transactions" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" } [13]=> object(WP_Post)#3053 (24) { ["ID"]=> int(17858) ["post_author"]=> string(1) "1" ["post_date"]=> string(19) "2023-07-27 12:38:53" ["post_date_gmt"]=> string(19) "2023-07-27 19:38:53" ["post_content"]=> string(340) "

This industry newsletter includes industry trends, market insights, key transaction highlights, and more.

If you’d like to connect and discuss more about our practice or our insights, please feel free to reach out to Adam Stormoen.

" ["post_title"]=> string(47) "Medical Equipment Services Newsletter - 1H-2023" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(6) "closed" ["post_password"]=> string(0) "" ["post_name"]=> string(40) "healthcare-technology-newsletter-h1-2023" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2023-07-27 13:09:19" ["post_modified_gmt"]=> string(19) "2023-07-27 20:09:19" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(60) "https://www.cascadiacapital.com/?post_type=news&p=17858" ["menu_order"]=> int(0) ["post_type"]=> string(4) "news" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" } [14]=> object(WP_Post)#3054 (24) { ["ID"]=> int(577) ["post_author"]=> string(1) "1" ["post_date"]=> string(19) "2023-04-25 08:00:59" ["post_date_gmt"]=> string(19) "2023-04-25 15:00:59" ["post_content"]=> string(945) "

Cascadia’s Healthcare professionals have over 50 years of collective experience and have originated and executed over $10 billion of M&A and financing transactions in the sector. In the process, we’ve had the good fortune of working with some of the most well-recognized buyers and investors in the business.

Emerging trends in the industry are driven by consumers demanding higher quality care with cost transparency, integrated health information, and better provider access and communication. The solutions lie at the intersection of healthcare services, equipment, and technology, where innovation provides for better, more accessible care at lower costs. Cascadia’s team is perfectly primed to meet the growing needs of the industry’s players, leveraging vast experience coupled with a thorough understanding of the market.

" ["post_title"]=> string(10) "Healthcare" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(6) "closed" ["post_password"]=> string(0) "" ["post_name"]=> string(10) "healthcare" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2024-02-14 10:04:58" ["post_modified_gmt"]=> string(19) "2024-02-14 17:04:58" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(64) "https://www.cascadiacapital.com/?post_type=industries&p=577" ["menu_order"]=> int(0) ["post_type"]=> string(10) "industries" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" } [15]=> object(WP_Post)#3055 (24) { ["ID"]=> int(519) ["post_author"]=> string(1) "1" ["post_date"]=> string(19) "2023-04-25 05:41:02" ["post_date_gmt"]=> string(19) "2023-04-25 12:41:02" ["post_content"]=> string(1103) "

Adam Stormoen is a Managing Director and Group Head of Healthcare at Cascadia Capital, focused on serving clients in Medical Products and Healthcare Services. Adam brings 20 years of investment banking experience advising and financing middle market private and public companies. Throughout his career he has closed several dozen M&A transactions, as well as public and private capital raises for clients across a wide array of Healthcare sub-verticals, including Medical Devices, Healthcare Services and Healthcare Technology.

Prior to joining Cascadia, Adam was a Managing Director at Duff & Phelps in the Healthcare Practice. Previously Adam provided investment banking services to clients while at Roth Capital Partners, Dougherty & Company, LLC and McGladrey Capital Markets.

Adam holds a BBA with a focus on Finance, Investments & Banking from the University of Wisconsin-Madison where he was a member of the football team.

" ["post_title"]=> string(13) "Adam Stormoen" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(6) "closed" ["post_password"]=> string(0) "" ["post_name"]=> string(13) "adam-stormoen" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2024-02-13 14:53:47" ["post_modified_gmt"]=> string(19) "2024-02-13 21:53:47" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(58) "https://www.cascadiacapital.com/?post_type=team&p=519" ["menu_order"]=> int(0) ["post_type"]=> string(4) "team" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" } [16]=> object(WP_Post)#3056 (24) { ["ID"]=> int(488) ["post_author"]=> string(1) "1" ["post_date"]=> string(19) "2023-04-25 05:10:46" ["post_date_gmt"]=> string(19) "2023-04-25 12:10:46" ["post_content"]=> string(731) "

Vitaliy Marchenko is a Director at Cascadia Capital in the firm’s Healthcare Services group, specializing in providing strategic advice to physician practice management clients. With over 12 years of investment banking experience, Vitaliy has a proven track record of advising founder and entrepreneur-owned companies with finesse and expertise.

Prior to joining Cascadia, Vitaliy was a VP at the Ziegler Companies in the Healthcare Services practice. Previously, Vitaliy provided investment banking services to clients while at Edgemont Capital. Vitaliy holds a BBA with a focus in Finance from Pacific Lutheran University.

" ["post_title"]=> string(17) "Vitaliy Marchenko" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(6) "closed" ["post_password"]=> string(0) "" ["post_name"]=> string(17) "vitaliy-marchenko" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2023-07-03 05:50:54" ["post_modified_gmt"]=> string(19) "2023-07-03 12:50:54" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(58) "https://www.cascadiacapital.com/?post_type=team&p=488" ["menu_order"]=> int(0) ["post_type"]=> string(4) "team" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" } [17]=> object(WP_Post)#3057 (24) { ["ID"]=> int(6712) ["post_author"]=> string(1) "1" ["post_date"]=> string(19) "2023-03-08 00:47:07" ["post_date_gmt"]=> string(19) "2023-03-08 00:47:07" ["post_content"]=> string(14479) "

The clinical trials technology and pharma services markets have long been ripe for innovation. Despite their role as an essential component of pharmaceutical development and efficacy, clinical trials have mostly succeeded in spite of themselves — typically crossing the finish line snarled in their own inefficiency, expense, and red tape. Slow and cumbersome recruitment efforts can send a trial back to square one on a dime, wasting valuable time and money: the average clinical trial comes with a price tag measured in millions of dollars per day and typically takes upwards of 10 years to complete. In addition, the historical centralization of activity has only served to extend timelines and diminish access and equity, reducing data accuracy across underrepresented populations.

In a recent amplification of fundraising activity, however, investors are taking note of companies that provide unique solutions to these enduring issues, investing in companies bringing technological advancements to the forefront of the clinical trials and pharma services ecosystems. Companies looking to follow suit have a massive opportunity to not only have successful financial outcomes but also genuinely change the healthcare landscape for the better, ultimately benefitting patients who desperately need new treatments to improve or save their lives.

Investors Are Quickly Taking Notice of Disruptive Technology That Increases Efficiency

With the recent innovative technology deployments in the clinical trials and pharma services environment, more data is flowing through the pipes than ever. Workflow service providers and data & interoperability companies are leveraging automation and technology to disrupt outdated models, benefiting trial sponsors and patients. Companies are also taking advantage of recent AI and machine learning advancements to absolve workflow issues, bringing immense value to pharmaceutical companies with increased process capacity, speed, and flexibility.

In 2021, the largest 20 pharmaceutical companies spent ~25% of their revenue, on average, on drug research and development (1). With the sheer volume of dollars funneled toward these efforts, it stands to reason that investors are eagerly searching to find and back solutions that make clinical trials more efficient and affordable.

As the ecosystem strives to become more streamlined and connected, tech-enabled health solutions that previously thrived under an initial operating umbrella may find more favorable homes under new, larger ownership with enhanced connectivity and reach. Our team recently worked with Inspirata on the sale of its digital pathology business to Fujifilm Corporation — a transaction that represents a bridge being built in the technological gap between pathology, radiology, and oncology to facilitate a more collaborative approach to care delivery (2). Large, diversified conglomerates, including Fujifilm and many other competitors with healthcare business stakes, are positioning for the rapid advancements on the technology front to stay competitive over the long haul and continue serving the pharma ecosystem.

Aspects of the clinical trials process that have historically served as speed bumps, like patient recruitment and randomization, have also seen massive improvements and increased attention from companies looking to disrupt stale processes. Randomizing a patient into a trial (successfully matching for the trial therapy and study) has historically generated far less than a 3% likelihood of success. This issue is newly being confronted with automation, machine learning, enhanced PCP networks — and even social media campaigns — to match suitable patients to the correct trials and address workflow issues.

We also recently worked with the team at SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options, on a $35 million fundraise to accelerate the growth of its existing software-driven recruitment efforts(3). SubjectWell serves nearly all of the largest pharmaceutical companies in the world, matching patients using its proprietary software engine and producing randomization rates far above industry standards.

“SubjectWell expands access to clinical trials by engaging the 96% of the population that has never participated in clinical research,” said SubjectWell CEO Ivor Clarke. “This approach allows us to engage a much more diverse patient population as we register 250,000 new patients per month.”(4)

Medable, a cloud platform for patient-centered clinical research, last year announced a $304 million fundraise, the proceeds of which are focused on “using digital technologies to make clinical trials accessible for everyone everywhere, bringing effective therapies to patients faster.”(5)

Technological innovations that increase efficiency — and the companies that deploy them — have therefore piqued investor interest and turbocharged funding activity. Faster trials and increased patient recruitment success can save customers hundreds of millions of dollars in direct costs and time to market. A value proposition that compelling to pharmaceutical companies is a bright green light for investors who may want to tap into the pharmaceutical market without taking on the risk of potentially landing on the wrong side of a failed clinical trial.

Decentralization: Bringing Trials to All Patients

Efforts to decentralize the clinical trials process have not only made it easier to recruit qualified patients, they have also served to increase the diversity and representation of patients that are ultimately admitted. This increase in patient recruitment, retention, and data diversity leads to an increased sample size of accurate data and faster trials — ultimately saving money and lives. All of the above can be compelling to investors. In some cases, it may also contribute to satisfying the Environmental, Social, and Governance (ESG) mandates of their underlying Limited Partners.

Two larger trends in healthcare have played a major role in decentralizing the ecosystem: consumerization and the implementation of remote patient monitoring technologies. Companies like Walmart, CVS, Kroger, and Walgreens have begun to move into the primary care and clinical trials spaces, broadening the access and scope of trials. Remote patient monitoring technologies allow patients to be observed in their own homes at any step of the process, and the data garnered can efficiently return to stakeholders in a free flow of information, saving precious time and money.

Investors have taken note of companies taking steps toward decentralization, shown in fundraisings such as Paradigm’s $203 million Series A, announced in January 2023. The platform was created with the mission to “build a more equitable clinical research ecosystem” and “make clinical trials a care option for all patients.”(6)

Our experience in the market suggests that if a company has the ability to contribute to decentralization — thereby decreasing time and cost and increasing access and data accuracy for the broader population— this further adds to the appeal for investors.

Checking the Sector’s Vitals

The clinical trials technology and pharma services sectors are much sturdier compared to others in the broader healthcare landscape, only further facilitating investor activity in the space. Drug sales are generally resistant to macroeconomic conditions, leading to the sector’s defensible position against the broader market. Although the industry saw a slight decline/flat trend of -4.7% in transaction activity and volume from 2021 to 2022, the change was substantially smaller when compared to the 21.5%(7) drop in broader healthcare technology and digital health.

Investor attention on the space is at an all-time high, and not just on the private markets side. In a year where strategics lie largely dormant on the M&A front with their market caps hammered, we have seen robust interest, and more strategic activity happening here than in any other space.

Investors of all stripes are looking for consistent year-over-year growth, diversification in the customer base and areas of focus, strong gross margins through competitive differentiation, and a clear path to profitability.

A Future of Innovation and Activity

Over the last few years, companies have worked to breathe new life into the lagging clinical trials and pharma services sectors, infusing innovative technologies into historically inefficient components of the clinical trials process. Patient randomization and recruitment have always been clunky, failure-prone constituents, and clinical trials data has been traditionally tough to unlock.

Clinical trials technology and pharma services companies have raised millions to focus on placing the right patients in the proper trials, speeding up workflows, and cutting costs. The ecosystem's decentralization has also contributed to making trials more accessible and equitable while reducing timelines and budgets. Sturdiness against macro conditions and the relative viability of individual, innovative companies continue to drive investor demand in these sectors.

The Cascadia team is active in ongoing discussions with companies and investors in the clinical trials technology and pharma services sectors. We are happy to lend our insights and experience as you evaluate your own next steps.

Reach out to our team to learn more


Sources:

(1) https://www.drugdiscoverytrends.com/pharmas-top-20-rd-spenders-in-2021/
(2) https://www.globenewswire.com/news-release/2022/12/19/2576269/0/en/Fujifilm-Announces-A%5B%E2%80%A6%5Dc-to-acquire-the-company-s-Digital-Pathology-Business.html
(3) https://www.businesswire.com/news/home/20221020005185/en/SubjectWell-Raises-35-Million-to-Expand-Patient-Access-to-New-Treatment-Options
(4) https://www.businesswire.com/news/home/20221020005185/en/SubjectWell-Raises-35-Million-to-Expand-Patient-Access-to-New-Treatment-Options
(5) https://www.businesswire.com/news/home/20211026005489/en/Medable-Secures-304-Million-in-Funding-at-2.1-Billion-Valuation-New-Round-Co-Led-by-Blackstone-Growth-GSR-Ventures-and-Tiger-Global
(6) https://www.paradigm.inc/news/paradigm-launches-to-rebuild-clinical-research
(7) https://rockhealth.com/insights/2022-year-end-digital-health-funding-lessons-at-the-end-of-a-funding-cycle/

" ["post_title"]=> string(103) "Investors Reward Innovation and Seek Decentralization in Clinical Trials Technology and Pharma Services" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(6) "closed" ["post_password"]=> string(0) "" ["post_name"]=> string(103) "investors-reward-innovation-and-seek-decentralization-in-clinical-trials-technology-and-pharma-services" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2023-06-23 01:46:11" ["post_modified_gmt"]=> string(19) "2023-06-23 08:46:11" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(141) "https://www.cascadiacapital.com/news/investors-reward-innovation-and-seek-decentralization-in-clinical-trials-technology-and-pharma-services/" ["menu_order"]=> int(0) ["post_type"]=> string(4) "news" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" } [18]=> object(WP_Post)#3058 (24) { ["ID"]=> int(3710) ["post_author"]=> string(1) "1" ["post_date"]=> string(19) "2023-01-01 00:01:00" ["post_date_gmt"]=> string(19) "2023-01-01 07:01:00" ["post_content"]=> string(0) "" ["post_title"]=> string(20) "Inspirata / FujiFilm" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(6) "closed" ["post_password"]=> string(0) "" ["post_name"]=> string(18) "inspirata-fujifilm" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2023-07-19 11:57:55" ["post_modified_gmt"]=> string(19) "2023-07-19 18:57:55" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(64) "https://www.cascadiacapital.com/transactions/inspirata-fujifilm/" ["menu_order"]=> int(0) ["post_type"]=> string(12) "transactions" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" } [19]=> object(WP_Post)#3749 (24) { ["ID"]=> int(6726) ["post_author"]=> string(1) "1" ["post_date"]=> string(19) "2022-12-09 08:00:30" ["post_date_gmt"]=> string(19) "2022-12-09 08:00:30" ["post_content"]=> string(4116) "

Cascadia Capital, an investment bank serving middle market clients globally, today announced it acted as the exclusive financial advisor to The Colon, Stomach, and Liver Center (“CSL”) and Loudoun Endoscopy Group (“LEG”) in partnership with One GI®, a gastroenterology healthcare services organization and portfolio company of Webster Equity Partners. The agreement also includes the state-of-the-art Loudoun Endoscopy Center.

Formed in April 2020, One GI is comprised of leading gastroenterology practices throughout the Eastern US. Established in 2003, CSL's three board certified gastroenterologists and two advanced practice providers (APPs) deliver comprehensive gastrointestinal and hepatology care to patients in Northern Virginia, West Virginia, and Maryland.

Headquartered in Nashville, Tennessee, One GI identifies and partners with leading gastroenterology practices that are seeking a strategic alliance to provide capital and management services to help foster growth, drive economies of scale, and deliver the highest quality care to patients.

One GI’s partnership with CSL and LEG in Northern Virginia further validates its foundational value of delivering world class GI care in community based practices, and the expansion in Virginia aligns with One GI's commitment to strategic growth.

"We are excited to partner with One GI to help us continue to improve the well-being of our patients and expand our commitment to meeting the growing need for GI and liver healthcare in Loudoun County and our neighboring communities,” said Satinder Gill, MD, CSL founding physician. “Our longstanding relationship with Cascadia Capital helped us find a strong partner in One GI. I’m grateful to Cascadia for their insightful counsel in selecting a partner who valued our unique care model.”

“We are excited for Dr. Gill and this long-term partnership with One GI as they look to grow a strong presence in the Virginia market,” added Vitaliy Marchenko, Senior Vice President at Cascadia Capital.

“Cascadia’s Healthcare Team continues to build out its healthcare services specialty coverage. This transaction demonstrates yet another area of expertise for our team within physician services as we continue advising GI, Fertility, Behavioral Health, Cariology & Vascular, Dermatology, Retina, and Oral Surgery physicians,” added Kevin Cable, Cascadia Managing Director.

This acquisition represents another successful transaction for Cascadia in the healthcare services sector. Past clients include Seattle Reproductive Medicine, Psychiatric Centers of San Diego and Utah Fertility Center.

For more information about this transaction, please contact the Cascadia Capital deal team:

Kevin Cable
Managing Director
kcable@cascadiacapital.com
(206) 696-7922

Vitaliy Marchenko
Senior Vice President
vmarchenko@cascadiacapital.com
(253) 314-3143

Other senior members of the Cascadia Healthcare team include:

Adam Stormoen
Managing Director
astormoen@cascadiacapital.com
(612) 260-8060

Novan Le
Vice President
nle@cascadiacapital.com
(206) 436-2510

" ["post_title"]=> string(116) "Cascadia Capital Advises The Colon, Stomach, and Liver Center and Loudoun Endoscopy Group in Partnership with One GI" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(6) "closed" ["post_password"]=> string(0) "" ["post_name"]=> string(114) "cascadia-capital-advises-the-colon-stomach-and-liver-center-and-loudoun-endoscopy-group-in-partnership-with-one-gi" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2023-07-06 03:00:08" ["post_modified_gmt"]=> string(19) "2023-07-06 10:00:08" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(152) "https://www.cascadiacapital.com/news/cascadia-capital-advises-the-colon-stomach-and-liver-center-and-loudoun-endoscopy-group-in-partnership-with-one-gi/" ["menu_order"]=> int(0) ["post_type"]=> string(4) "news" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" } } ["post_count"]=> int(20) ["current_post"]=> int(-1) ["before_loop"]=> bool(true) ["in_the_loop"]=> bool(false) ["post"]=> object(WP_Post)#3040 (24) { ["ID"]=> int(19536) ["post_author"]=> string(1) "1" ["post_date"]=> string(19) "2024-03-05 16:11:44" ["post_date_gmt"]=> string(19) "2024-03-05 23:11:44" ["post_content"]=> string(2878) "

Cascadia Capital, an investment bank serving middle market clients globally, is pleased to announce it acted as the exclusive financial advisor to Fertility Specialists of Texas ("FST"), as it joins First Fertility’s network of high-performing family building centers. This transaction is Cascadia's eighth successful engagement in advising clients within the reproductive health sector.

“We are delighted with the culmination of this transaction, uniting a well-regarded regional leader in reproductive health with the esteemed First Fertility network. This strategic addition marks a significant expansion into the Texas market, aligning seamlessly with the company's overarching vision to surpass conventional standards in fertility care through the delivery of unparalleled services. Our involvement in facilitating this prosperous partnership underscores Cascadia's expertise and commitment to the fertility sector, with this transaction representing the eighth successful partnership we have advised on," remarked Vitaliy Marchenko, Director at Cascadia.

With a flagship office and IVF lab located in Plano, Texas, FST is a renowned fertility center that has consistently showcased its commitment to compassionate and cutting-edge fertility treatments since its inception in 2005. By delivering top-notch patient service and exceptional pregnancy success rates, FST has grown tremendously with a team of six world-renowned, board-certified physicians and six practice locations throughout the Dallas-Fort Worth Metroplex.

First Fertility continues to solidify its position as one of the most rapidly expanding physician-centered fertility care networks in the nation. Backed by Sverica Capital, First Fertility fosters collaboration among physicians and medical leaders, providing fertility-focused practices with a strong foundation for innovation and growth.

“As the founder and medical director of Fertility Specialists of Texas, I am immensely excited to embark on this incredible journey alongside First Fertility,” adds Jerald Goldstein, MD. “This partnership represents a remarkable opportunity to unite our expertise and passion for reproductive medicine, driving us to reach new heights in assisting individuals and couples on their path to parenthood. Together, we will shape the future of fertility with compassion and unparalleled personalized care, as we continue to help patients from Texas, throughout the country, and around the world, to fulfill their family-building dreams."


" ["post_title"]=> string(125) "Cascadia Advises Fertility Specialists of Texas in its Acquisition by First Fertility, a portfolio company of Sverica Capital" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(6) "closed" ["post_password"]=> string(0) "" ["post_name"]=> string(124) "cascadia-advises-fertility-specialists-of-texas-in-its-acquisition-by-first-fertility-a-portfolio-company-of-sverica-capital" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2024-03-06 13:54:59" ["post_modified_gmt"]=> string(19) "2024-03-06 20:54:59" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(60) "https://www.cascadiacapital.com/?post_type=news&p=19536" ["menu_order"]=> int(0) ["post_type"]=> string(4) "news" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" } ["comment_count"]=> int(0) ["current_comment"]=> int(-1) ["found_posts"]=> int(183) ["max_num_pages"]=> int(10) ["max_num_comment_pages"]=> int(0) ["is_single"]=> bool(false) ["is_preview"]=> bool(false) ["is_page"]=> bool(false) ["is_archive"]=> bool(true) ["is_date"]=> bool(false) ["is_year"]=> bool(false) ["is_month"]=> bool(false) ["is_day"]=> bool(false) ["is_time"]=> bool(false) ["is_author"]=> bool(false) ["is_category"]=> bool(false) ["is_tag"]=> bool(false) ["is_tax"]=> bool(true) ["is_search"]=> bool(false) ["is_feed"]=> bool(false) ["is_comment_feed"]=> bool(false) ["is_trackback"]=> bool(false) ["is_home"]=> bool(false) ["is_privacy_policy"]=> bool(false) ["is_404"]=> bool(false) ["is_embed"]=> bool(false) ["is_paged"]=> bool(false) ["is_admin"]=> bool(false) ["is_attachment"]=> bool(false) ["is_singular"]=> bool(false) ["is_robots"]=> bool(false) ["is_favicon"]=> bool(false) ["is_posts_page"]=> bool(false) ["is_post_type_archive"]=> bool(false) ["query_vars_hash":"WP_Query":private]=> string(32) "ff635706b5629dfdd33db9c5c89bb7ac" ["query_vars_changed":"WP_Query":private]=> bool(false) ["thumbnails_cached"]=> bool(false) ["allow_query_attachment_by_filename":protected]=> bool(false) ["stopwords":"WP_Query":private]=> NULL ["compat_fields":"WP_Query":private]=> array(2) { [0]=> string(15) "query_vars_hash" [1]=> string(18) "query_vars_changed" } ["compat_methods":"WP_Query":private]=> array(2) { [0]=> string(16) "init_query_flags" [1]=> string(15) "parse_tax_query" } }